Search Within

Michael David Offin

  1. "Radiology, Department of"
Formats
  1. Meeting Abstract (23)
  2. Journal Article (22)
  3. Correspondence (1)
Groups
  1. Department of Medicine (46)
  2. Radiology, Department of (46)
  3. Solid Tumor Oncology Division (46)
  4. Thoracic Oncology (46)
  5. Weinberg Fellows (46)
  6. Body Imaging Service (32)

More Groups

People
  1. Mark Kris (26)
  2. Charles Rudin (25)
  3. Bob Li (24)
  4. Michelle Ginsberg (21)
  5. Alexander Drilon (20)
  6. Maria Arcila (17)

More People

Years
  1. 2025 (1)
  2. 2024 (12)
  3. 2023 (6)
  4. 2022 (7)
  5. 2021 (3)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Journal of Thoracic Oncology (6)
  3. JCO Precision Oncology (4)
  4. Clinical Cancer Research (3)
  5. Annals of Oncology (2)
  6. JTO Clinical and Research Reports (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (18)
  2. Elsevier Inc. (9)
  3. American Association for Cancer Research (4)
  4. Oxford University Press (4)
  5. Elsevier BV (2)
  6. Nature Publishing Group (2)

More Publishers

Results (46)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combining a WT1 vaccine (Galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1–expressing diffuse pleural mesothelioma: A phase 1 study
    Journal Article

    Agrawal, P.; Offin, M.; Lai, V.; Ginsberg, M. S.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ho, T.; Wong, P.; Zauderer, M. G.
    JTO Clinical and Research Reports (2025)

    Fulltext@MSK | Save
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Targeting TROP-2 in diffuse pleural mesothelioma
    Meeting Abstract

    Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Multi-center phase I study of concurrent paxalisib and radiation therapy in patients with solid tumor brain metastases (BM) or leptomeningeal metastases (LM) harboring PI3K pathway mutations
    Meeting Abstract

    Imber, B. S.; Kotecha, R.; Blau, M. H.; Friend, J.; Young, R. J.; Offin, M.; Michelle, R.; Diamond, E.; Yang, J. T.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Early circulating tumor DNA shedding kinetics for prediction of platinum sensitivity in patients with small cell lung cancer
    Journal Article

    Murciano-Goroff, Y. R.; Hui, A. B. Y.; Araujo Filho, J. A.; Hamilton, E. G.; Chabon, J. J.; Moding, E. J.; Bonilla, R. F.; Lebow, E. S.; Gomez, D.; Rimner, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Tumor-agnostic genomic and clinical analysis of BRAF fusions identifies actionable targets
    Journal Article

    Chen, M. F.; Yang, S. R.; Tao, J. J.; Desilets, A.; Diamond, E. L.; Wilhelm, C.; Rosen, E.; Gong, Y.; Mullaney, K.; Torrisi, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas: Results of a prospective pilot study
    Meeting Abstract

    Offin, M.; Lavin, Y.; Zatzman, M.; Sauter, J. L.; Ceglia, N.; Travis, W. D.; Aly, R. G.; Rimner, A.; Shepherd, A.; Simone, C. B. 2nd; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Combining a WT1 cancer vaccine (galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1-expressing diffuse pleural mesothelioma (DPM): A phase I study
    Meeting Abstract

    Agrawal, P.; Offin, M.; Ginsberg, M. S.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ho, T.; Wong, P.; Zauderer, M. G.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save